Ireland
--:--IST
Recruiting Observational

Chronic Myeloid Leukemia (CML) Real-Life Database

NCT05963061 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2014-04-16
Last updated
2024-04-09

Condition(s) studied

Chronic Myeloid Leukemia (CML)

Study summary

Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient diagnosed for chronic myelocytic leukemia Exclusion Criteria: * CML allograft without TKI treatment * Refusal or inability to sign the consent

Primary outcome measure(s)

  • Clinical and biological data collection — Until death or last follow up (up to 30 years)
    Aims of the registry are the collection of clinical data to gain further insights about patients's CML treated with ITK's (treatment, prognosis, therapeutical response).

Trial sites (14)

FacilityCityRegionStatus
CH Annecy Genevois Annecy France Recruiting
University Hospital, Caen Caen France Recruiting
CHU Clemront-Ferrand Clermont-Ferrand France Recruiting
Centre Hospitalier Emile Roux Le Puy-en-Velay France Recruiting
University Hospital, Limoges Limoges France Recruiting
Institut Paoli-Calmettes Marseille France Recruiting
Centre Hospital, Nancy Nancy France Recruiting
Bicetre Hospital Paris France Recruiting
Hopital Paul Brousse Paris France Recruiting
Rennes University Hospital Rennes France Recruiting
Centre Hospitalier de Rochefort Rochefort France Recruiting
Centre Hospitalier Universitaire de Saint Etienne Saint-Etienne France Recruiting
University Hospital, Toulouse Toulouse France Recruiting
Versailles Hospital Versailles France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05963061 on ClinicalTrials.gov ↗ ← All trials in France